4.7 Review

β-lactam antibiotics: An overview from a medicinal chemistry perspective

期刊

出版社

ELSEVIER FRANCE-EDITIONS SCIENTIFIQUES MEDICALES ELSEVIER
DOI: 10.1016/j.ejmech.2020.112829

关键词

Penicillin; Cephalosporin; Monobactam; Carbapenem; Beta-lactamase; Beta-lactam

资金

  1. CNPq
  2. CAPES [001]
  3. FAPERJ
  4. INCT-INOFAR [573.564/2008-6, E-26/170.020/2008]

向作者/读者索取更多资源

beta-Lactam antibiotics are one of the most relevant drug classes of antibacterial agents worldwide. The discovery and the market of first beta-lactam antibiotic (Penicillin G) is a symbolic landmark of modern chemotherapy. Since then, several other beta-lactam antibiotics have been introduced in the therapy, revolutionizing the treatment of bacterial infections. Their antibacterial efficacy has been kept in check by the emergence of bacterial resistance. Among the resistance mechanisms, the expression of beta-lactamase enzymes is one of the most studied and prevalent. The combined use of beta-lactamase inhibitors with broad spectrum activity beta-lactam antibiotics has been an effective strategy to circumvent the resistance issue. This review discusses, with a focus on structural aspects, the different classes of beta-lactam antibiotics (penicillins, cephalosporins, carbapenems, monobactams and penems) in light of their stability, sensitivity to beta-lactamases, mechanism of action and spectrum of antimicrobial activity. beta-Lactamase inhibitors (structurally correlated and non-correlated to the beta-lactam system) and their proposed inhibition mechanisms are also discussed. (c) 2020 Elsevier Masson SAS. All rights reserved.

作者

我是这篇论文的作者
点击您的名字以认领此论文并将其添加到您的个人资料中。

评论

主要评分

4.7
评分不足

次要评分

新颖性
-
重要性
-
科学严谨性
-
评价这篇论文

推荐

暂无数据
暂无数据